Envisioning the future of SGLT2 inhibitors in the treatment of patients with diabetes and cardiovascular disease: a roundtable discussion.

27 August 2018 (13:45 - 13:55)

Organised by:

University of Toronto, Toronto (Canada)

Klinikum Ludwigshafen, Ludwigshafen (Germany)

University of Texas Southwestern Medical Center, Dallas (United States of America)

Memphis (United States of America)

Professor D. McGuire (Dallas, US)

Doctor A. Gitt (Ludwigshafen, DE)

Professor L. Leiter (Toronto, CA)

Doctor S. Dagogo-Jack (Memphis, US)

Professor D. McGuire (Dallas, US) Doctor S. Dagogo-Jack (Memphis, US) Doctor A. Gitt (Ludwigshafen, DE) Professor L. Leiter (Toronto, CA)

27 August 2018 13:45 CET